Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | EGFR | P00533 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 9/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.37 |
| ▸ | KLF10 | Q13118 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12987933 | 0.82 | AR (0.40) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL5651250 | 0.78 | TYR (0.45) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL682899 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL6563317 | 0.77 | KIF11 (0.41) | ALDH1A1HPGDHSD17B10TDP1ESR1 | |
| SCHEMBL1244431 | 0.76 | ESR1 (0.55) | ALDH1A1ALOX15HPGDHSD17B10ESR1 | |
| SCHEMBL50705 | 0.75 | ALDH1A1 (1.00) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL29358687 | 0.75 | ALDH1A1 (1.00) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL1501111 | 0.75 | ALDH1A1 (0.73) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL768840 | 0.75 | ALDH1A1 (0.53) | ALDH1A1ALOX15HPGDHSD17B10TDP1 | |
| SCHEMBL10227953 | 0.74 | SCN10A (0.38) | ALDH1A1ESR1SCN10ACYP19A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385934-B1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL SCIENT IND RES (IN) | 2016-05-18 | — | — | EP | claimed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | claimed |
| US-20140135393-A1 | SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-05-15 | — | — | US | claimed |
| WO-2012140574-A1 | SUBSTITUTED CATECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-10-18 | — | — | WO | claimed |
| EP-2385934-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | Council of Scientific & Industrial Research (IN) | 2011-11-16 | — | — | EP | claimed |
| US-8041964-B2 | Ultra low power wake-up circuit | COVIDIEN AG (CH) | 2011-10-18 | — | — | US | claimed |
| WO-2010079423-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-15 | — | — | WO | claimed |
| EP-2385934-B1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL SCIENT IND RES (IN) | 2016-05-18 | — | — | EP | disclosed |
| EP-2385934-B1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL SCIENT IND RES (IN) | 2016-05-18 | — | — | EP | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9290473-B2 | Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO) | COUCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-03-22 | — | — | US | disclosed |
| WO-2012140574-A1 | SUBSTITUTED CATECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-10-18 | — | — | WO | disclosed |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-07-26 | — | — | US | disclosed |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-07-26 | — | — | US | disclosed |
| EP-2385934-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | Council of Scientific & Industrial Research (IN) | 2011-11-16 | — | — | EP | disclosed |
| WO-2011133951-A1 | PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-10-27 | — | — | WO | disclosed |
| US-8041964-B2 | Ultra low power wake-up circuit | COVIDIEN AG (CH) | 2011-10-18 | — | — | US | disclosed |
| WO-2010079423-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135393-A1 | SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | IL5, IL4, IL33 | ALDH1A1 1102/4885ALOX15 34/4885HPGD 674/4885 |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | NOS2, NOS3, NOS1 | ALDH1A1 2529/4885ALOX15 920/4885HPGD 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.